Zealand Pharma A/S
ZLDPF
$62.50
-$0.79-1.25%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.07M | 11.13M | 53.63M | 50.23M | 50.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.07M | 11.13M | 53.63M | 50.23M | 50.00M |
| Cost of Revenue | 1.12M | 2.76M | 4.49M | 2.36M | 1.69M |
| Gross Profit | 7.95M | 8.37M | 49.14M | 47.87M | 48.30M |
| SG&A Expenses | 58.47M | 45.66M | 39.09M | 35.53M | 31.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 14.00K | 470.00K | -214.10K | -214.10K | -1.23M |
| Total Operating Expenses | 193.04M | 173.50M | 157.90M | 144.42M | 131.24M |
| Operating Income | -183.98M | -162.37M | -104.27M | -94.19M | -81.24M |
| Income Before Tax | -157.05M | -153.68M | -103.59M | -108.06M | -102.72M |
| Income Tax Expenses | -671.40K | -671.70K | -661.40K | -697.70K | -744.40K |
| Earnings from Continuing Operations | -156.38 | -153.01 | -102.93 | -107.37 | -101.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -156.38M | -153.01M | -102.93M | -107.37M | -101.97M |
| EBIT | -183.98M | -162.37M | -104.27M | -94.19M | -81.24M |
| EBITDA | -217.76M | -196.30M | -138.49M | -127.52M | -75.39M |
| EPS Basic | -2.36 | -2.42 | -1.68 | -1.81 | -1.81 |
| Normalized Basic EPS | -1.89 | -1.90 | -1.41 | -1.27 | -0.90 |
| EPS Diluted | -2.36 | -2.42 | -1.69 | -1.82 | -1.82 |
| Normalized Diluted EPS | -1.89 | -1.90 | -1.41 | -1.27 | -0.90 |
| Average Basic Shares Outstanding | 265.72M | 253.35M | 241.07M | 236.48M | 226.35M |
| Average Diluted Shares Outstanding | 265.72M | 253.35M | 242.97M | 238.38M | 228.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
